Table 4.
Univariate Analysis for Overall Survival Comparing Patients with Bone Oligometastasis vs Patients without Any Metastasis
Subtype | Hazard Ratio (95% CI) | P |
---|---|---|
HR+/HER2- | 7.50 (6.95-8.09) | < 0.0001* |
HR+/HER2+ | 4.61 (3.52-6.03) | < 0.0001* |
HR-/HER2+ | 4.73 (3.40-6.59) | < 0.0001* |
TNBC | 8.85 (7.58-10.34) | < 0.0001* |
P values were for log-rank tests; * Significant P value (<0.05)